Selective Laser Trabeculoplasty in the Era of OTC Blood Thinners: Hyphema and IOP Spikes

This audio article is from VisualFieldTest.com.Read the full article here: https://visualfieldtest.com/en/selective-laser-trabeculoplasty-in-the-era-of-otc-blood-thinners-hyphema-and-iop-spikesTest your visual field online: https://visualfieldtest.comExcerpt:Selective Laser Trabeculoplasty in the Era of OTC Blood Thinners: Hyphema and IOP SpikesSelective Laser Trabeculoplasty (SLT) and Argon Laser Trabeculoplasty (ALT) are laser treatments used to lower eye pressure in glaucoma. SLT uses a short, low-energy laser pulse to target just the pigmented cells of the eye’s drainage mesh (the trabecular meshwork) (), whereas ALT (older technology) uses a higher-energy laser that can cause more tissue damage (). Both are generally safe and outpatient procedures. However, in recent years many patients take over-the-counter (OTC) “blood-thinning” supplements or medications (like low-dose aspirin, fish oil, vitamin E, ginkgo biloba, etc.) for heart health or general wellness. Patients often ask whether these supplements could increase bleeding or pressure complications after SLT/ALT. This article reviews the evidence. We explain hyphema (bleeding inside the front of the eye) and transient intraocular pressure (IOP) spikes, and how (if at all) anticoagulant supplements might affect their incidence or severity. We also discuss risk factors, what to tell patients before the laser, and how doctors monitor and treat these complications after the procedure.How Laser Trabeculoplasty WorksSLT and ALT aim to improve fluid drainage from the eye to lower the pressure. In ALT, the argon laser causes visible burns and scarring on the trabecular meshwork, which can work to open nearby drainage channels but also often causes inflammation and short-term pressure rises (). SLT, developed later, uses very short pulses that selectively heat only the pigmented cells in the meshwork (). This triggers a biological response (release of cytokines like interleukins and a change in local cells) that helps clear debris and improve outflow, without permanent scarring () (). Because SLT is gentler (about 1% of the energy of ALT) (), it typically has fewer side effects like prolonged inflammation. Both methods are still used, though SLT is more popular today due to its safety and repeatability. After the laser, patients still take medications as needed, but SLT often lets some people reduce their eye drops.Bleeding in the Eye (Hyphema) After Laser TrabeculoplastyA hyphema is blood in the anterior chamber of the eye (the fluid-filled space between the cornea and iris). It can occur if blood vessels in the angle or iris are damaged. After laser trabeculoplasty, significant hyphema is very rare. In fact, the published literature documents only two confirmed cases of hyphema after SLT () (). In one case, a 77-year-old patient who was using non-steroidal anti-inflammatory drugs (NSAIDs) (oral painkillers and anti-inflammatory eye drops) developed a hyphema three days after SLT (). In the other reported case, a small bleed occurred during the SLT procedure but it cleared on its own (). Importantly, no cases of hyphema after ALT have been reported (). These isolated reports suggest that in most people, SLT or ALT will not cause any bleeding that is visible or harmful. If a tiny micro-bleed occurs in the meshwork, it usually does not leak into the chamber. The lack of data on supplementation means we can only speculate. It is mechanistically plausible that blood-thinning agents could make even a tiny vessel leak longer. During laser trabeculoplasty, energy can occasionally injure minute blood vessels in the trabecular meshwork or Schlemm’s canal (the fluid drainage channel). If a patient is taking strong antiplatelet or anticoSupport the show